‘Paxlovid rebound’ cases have experts scrambling for answers
Is it happening because of the antiviral or is this just how the virus behaves?
WHO strongly recommends COVID-19 pill Paxlovid for high-risk populations
Paxlovid may prevent more hospitalisations than its alternatives
Omicron may already be in most countries, WHO warns
People dismissing omicron infection as mild may fuel spread, says WHO
Antivirals can make ‘profound difference’ against more infectious, virulent strains of COVID-19
Those who will benefit from antiviral treatment should get the medicines on priority, say experts
COVID-19: How safe are antiviral drugs for environment?
Both chloroquine and hydroxychloroquine, for example, pose serious chronic threat to the aquatic environment
Effective oral drug for Hepatitis C approved by European agencies
Various patent barriers hinder its availability and affordability, especially in countries with high burden of disease